Faron Pharmaceuticals Oy

FARN.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents£13,532£9,503£29,979£6,875
Short-Term Investments£0£0£0£0
Receivables£0£201£0£0
Inventory£0£0£0£0
Other Curr. Assets£1,273£1,361£3,987£1,993
Total Curr. Assets£14,805£11,065£33,966£8,868
Property Plant & Equip (Net)£250£298£347£204
Goodwill£0£0£0£0
Intangibles£1,111£1,113£1,086£1,088
Long-Term Investments£0£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£38£45£61£60
Total NC Assets£1,399£1,456£1,494£1,352
Other Assets£0£0£0£0
Total Assets£16,204£12,521£35,460£10,220
Liabilities
Payables£5,634£4,876£17,473£8,971
Short-Term Debt£961£3,839£3,777£3,638
Tax Payable£0£0£0£0
Deferred Revenue£0£0£0£0
Other Curr. Liab.£1,232£1,456£2,243£2,403
Total Curr. Liab.£7,827£10,171£23,493£15,012
LT Debt£21,447£8,274£8,945£9,473
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£3,176£3,838£1,643£896
Total NC Liab.£24,623£12,112£10,588£10,369
Other Liabilities£0£0£0£0
Cap. Leases£265£303£344£213
Total Liabilities£32,450£22,283£34,081£25,381
Equity
Pref Stock£0£0£0£0
Common Stock£2,691£2,691£2,691£2,691
Retained Earnings-£216,137-£197,421-£186,181-£172,208
AOCI£0£0£184,869£154
Other Equity£197,200£184,968£0£154,202
Total Equity-£16,246-£9,762£1,379-£15,161
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£16,204£12,521£35,460£10,220
Net Debt£8,876£2,610-£17,257£6,236
Faron Pharmaceuticals Oy (FARN.L) Financial Statements & Key Stats | AlphaPilot